Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

The Institute of Human Virology, Nigeria (IHVN) has said it is pioneering a research project to develop a vaccine targeting ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...

Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

While the recent study by the Human Sciences Research Council (HSRC) revealed that people living with HIV in KwaZulu-Natal ...